Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Lee, Min-Soo
and
Chang, Hun Soo
2009.
Schizophrenia.
p.
218.
Remington, Gary
Foussias, George
and
Agid, Ofer
2010.
Progress in Defining Optimal Treatment Outcome in Schizophrenia.
CNS Drugs,
Vol. 24,
Issue. 1,
p.
9.
Lambert, Martin
Karow, Anne
Leucht, Stefan
Schimmelmann, Benno G.
and
Naber, Dieter
2010.
Remission in schizophrenia: validity, frequency, predictors, and patients' perspective 5 years later.
Dialogues in Clinical Neuroscience,
Vol. 12,
Issue. 3,
p.
393.
Masand, Prakash
O'Gorman, Cedric
and
Mandel, Francine S.
2011.
Clinical Global Impression of Improvement (CGI-I) as a valid proxy measure for remission in schizophrenia: Analyses of ziprasidone clinical study data.
Schizophrenia Research,
Vol. 126,
Issue. 1-3,
p.
174.
Kraemer, Susanne
Chartier, Florence
Augendre‐Ferrante, Béatrice
Psarra, Vassiliki
D'yachkova, Yulia
Beselin, Anke
and
Rouillon, Fréderic
2012.
Effectiveness of two formulations of oral olanzapine in patients with schizophrenia or bipolar disorder in a natural setting: results from a 1‐year European observational study.
Human Psychopharmacology: Clinical and Experimental,
Vol. 27,
Issue. 3,
p.
284.
Kortrijk, Hans E.
Mulder, Cornelis L.
van der Gaag, Mark
and
Wiersma, Durk
2012.
Symptomatic and functional remission and its associations with quality of life in patients with psychotic disorder in Assertive Community Treatment teams.
Comprehensive Psychiatry,
Vol. 53,
Issue. 8,
p.
1174.
Andreou, Christina
Roesch-Ely, Daniela
Veckenstedt, Ruth
Bohn, Francesca
Aghotor, Julia
Köther, Ulf
Pfueller, Ute
and
Moritz, Steffen
2013.
Predictors of early stable symptomatic remission after an exacerbation of schizophrenia: The significance of symptoms, neuropsychological performance and cognitive biases.
Psychiatry Research,
Vol. 210,
Issue. 3,
p.
729.
Nordon, C.
Rouillon, F.
Azorin, J. M.
Barry, C.
Urbach, M.
and
Falissard, B.
2014.
Trajectories of antipsychotic response in drug‐naive schizophrenia patients: results from the 6‐month ESPASS follow‐up study.
Acta Psychiatrica Scandinavica,
Vol. 129,
Issue. 2,
p.
116.
Cohen, Carl I.
and
Iqbal, Mudassar
2014.
Longitudinal Study of Remission Among Older Adults with Schizophrenia Spectrum Disorder.
The American Journal of Geriatric Psychiatry,
Vol. 22,
Issue. 5,
p.
450.
Pachoud, B.
Llorca, P.M.
Azorin, J.M.
Dubertret, C.
de Pierrefeu, I.
Gaillard, R.
and
Franck, N.
2015.
Comment améliorer les pratiques et interventions de soutien à l’insertion professionnelle des patients souffrant de schizophrénie en France ?.
L'Encéphale,
Vol. 41,
Issue. 6,
p.
507.
Rabanea-Souza, Thais
Akiba, Henrique T.
Berberian, Arthur A.
Bressan, Rodrigo A.
Dias, Álvaro M.
and
Lacerda, Acioly L.T.
2016.
Neuropsychological correlates of remission in chronic schizophrenia subjects: The role of general and task-specific executive processes.
Schizophrenia Research: Cognition,
Vol. 3,
Issue. ,
p.
39.
Lally, John
Ajnakina, Olesya
Stubbs, Brendon
Cullinane, Michael
Murphy, Kieran C.
Gaughran, Fiona
and
Murray, Robin M.
2017.
Remission and recovery from first-episode psychosis in adults: systematic review and meta-analysis of long-term outcome studies.
British Journal of Psychiatry,
Vol. 211,
Issue. 6,
p.
350.
Morozova, Margarita
Burminskiy, Denis
Rupchev, George
Lepilkina, Taissia
Potanin, Sergey
Beniashvili, Allan
Lavrovsky, Yan
Vostokova, Natalia
and
Ivaschenko, Alexander
2017.
5-HT6 Receptor Antagonist as an Adjunct Treatment Targeting Residual Symptoms in Patients With Schizophrenia.
Journal of Clinical Psychopharmacology,
Vol. 37,
Issue. 2,
p.
169.
Leonhardt, Bethany L.
Huling, Kelsey
Hamm, Jay A.
Roe, David
Hasson-Ohayon, Ilanit
McLeod, Hamish J.
and
Lysaker, Paul H.
2017.
Recovery and serious mental illness: a review of current clinical and research paradigms and future directions.
Expert Review of Neurotherapeutics,
Vol. 17,
Issue. 11,
p.
1117.
El Gharbi, I.
Chhoumi, M.
and
Mechri, A.
2019.
Rémission symptomatique et sa relation avec le fonctionnement social chez des patients tunisiens suivis pour schizophrénie.
L'Encéphale,
Vol. 45,
Issue. 1,
p.
15.
Cohen, Carl I.
2019.
Schizophrenia and Psychoses in Later Life.
p.
95.
Cheng, Zhang
Yuan, Yanbo
Han, Xue
Yang, Lei
Zeng, Xin
Yang, Fude
Lu, Zheng
Wang, Chuanyue
Deng, Hong
Zhao, Jingping
and
Yu, Xin
2020.
Which Subgroup of First-Episode Schizophrenia Patients Can Remit During the First Year of Antipsychotic Treatment?.
Frontiers in Psychiatry,
Vol. 11,
Issue. ,
Adanty, Christopher
Qian, Jessica
Wang, Yin
Remington, Gary
Shakeri, Ahmad
Borlido, Carol
Gerretsen, Philip
Graff-Guerrero, Ariel
and
De Luca, Vincenzo
2022.
Childhood trauma exposure and personality traits in schizophrenia patients.
Schizophrenia Research,
Vol. 241,
Issue. ,
p.
221.
van Opstal, Daniël P. J.
Kia, Seyed Mostafa
Jakob, Lea
Somers, Metten
Sommer, Iris E. C.
Winter‐van Rossum, Inge
Kahn, René S.
Cahn, Wiepke
and
Schnack, Hugo G.
2024.
Psychosis Prognosis Predictor: A continuous and uncertainty‐aware prediction of treatment outcome in first‐episode psychosis.
Acta Psychiatrica Scandinavica,
Comments
No Comments have been published for this article.